{
 "PrintNo":"A7501","Session":2025,"Chamber":"ASSEMBLY","BillType":"Assembly","Published":"2025-03-28T14:12:03.138668Z",
 "Status":"IN_ASSEMBLY_COMM","Committee":"Health",
 "Milestones":[{"Type":"IN_ASSEMBLY_COMM","Date":"2025-03-28","Committee":"Health"}],
 "Actions":[{"Text":"REFERRED TO HEALTH","Date":"2025-03-28","Chamber":"ASSEMBLY"}],
 "Sponsors":[{"ID":610,"Name":"Edward Braunstein","Short":"BRAUNSTEIN"}],
 "Title":"Adds tianeptine sodium to the list of Schedule II of controlled substances",
 "Summary":"Adds tianeptine sodium to list of Schedule II of controlled substances.","LawSection":"Public Health Law",
 "LawCode":"Amd ยง3306, Pub Health L",
 "ActClause":"AN ACT to amend the public health law, in relation to adding tianeptine sodium to schedule II of controlled substances",
 "SameAsPrintNo":"S3351-2025","PreviousVersions":["A7550-2019","A344-2021","A9188-2023"]
}